Aldo Spanjaard
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- DNA Repair Mechanisms 4
- Epigenetics and DNA Methylation 1
- DNA and Nucleic Acid Chemistry 1
- Glycosylation and Glycoproteins Research 1
- Oncology 3
- CAR-T cell therapy research 2
- Cancer Immunotherapy and Biomarkers 1
- PARP inhibition in cancer therapy 1
- Co-authors
- Heinz Jacobs (6 shared papers)Nikolina Bąbała (1 shared paper)Bas Pilzecker (2 shared papers)Jannie Borst (1 shared paper)Yanling Xiao (1 shared paper)Tomasz Ahrends (1 shared paper)Marc A. Hogenbirk (1 shared paper)Cor Lieftink (2 shared papers)
- Journals
- International Journal of Molecular Sciences (1 paper)Frontiers in Chemistry (1 paper)Proceedings of the National Academy of Sciences (1 paper)Nucleic Acids Research (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- NetherlandsUnited States
In The Last Decade
Aldo Spanjaard
6 papers receiving 296 citations
Peers
Comparison fields: 5 of 46
- Immunology 231
- Oncology 190
- Biotechnology 13
- Microbiology 1
- Molecular Biology 75
Countries citing papers authored by Aldo Spanjaard
This map shows the geographic impact of Aldo Spanjaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aldo Spanjaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aldo Spanjaard more than expected).
Fields of papers citing papers by Aldo Spanjaard
This network shows the impact of papers produced by Aldo Spanjaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aldo Spanjaard. The network helps show where Aldo Spanjaard may publish in the future.
Co-authors
The 25 scholars most cited alongside Aldo Spanjaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 273 | |
| 2 | 2020 | 9 | |
| 3 | 2023 | 6 | |
| 4 | 2022 | 6 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 2 |
About Aldo Spanjaard
Aldo Spanjaard is a scholar working on Molecular Biology, Oncology, Immunology, Genetics and Cancer Research, having authored 6 papers that have together received 300 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (4 papers), CAR-T cell therapy research (2 papers), Epigenetics and DNA Methylation (1 paper), DNA and Nucleic Acid Chemistry (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Immunotherapy and Immune Responses (1 paper), PARP inhibition in cancer therapy (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Immunology (231 citations), Oncology (190 citations), Biotechnology (13 citations), Microbiology (1 citation) and Molecular Biology (75 citations). Aldo Spanjaard has collaborated with scholars based in Netherlands and United States. Frequent co-authors include Heinz Jacobs, Nikolina Bąbała, Bas Pilzecker, Jannie Borst, Yanling Xiao, Tomasz Ahrends, Marc A. Hogenbirk, Cor Lieftink, Colin E.J. Pritchard and Ji‐Ying Song. Their work appears in journals such as International Journal of Molecular Sciences, Frontiers in Chemistry, Proceedings of the National Academy of Sciences, Nucleic Acids Research and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.